Immuno-Oncology biomarkers 2010 and beyond: Perspectives from the iSBTc/SITC biomarker task force

The International Society for Biological Therapy of Cancer (iSBTc, recently renamed the Society for Immunotherapy of Cancer, SITC) hosted a one-day symposium at the National Institutes of Health on September 30, 2010 to address development and application of biomarkers in cancer immunotherapy. The s...

Descripción completa

Detalles Bibliográficos
Autores principales: Butterfield, Lisa H, Disis, Mary L, Khleif, Samir N, Balwit, James M, Marincola, Francesco M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014892/
https://www.ncbi.nlm.nih.gov/pubmed/21138581
http://dx.doi.org/10.1186/1479-5876-8-130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014892/
https://www.ncbi.nlm.nih.gov/pubmed/21138581
http://dx.doi.org/10.1186/1479-5876-8-130

Ejemplares similares